Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MYi
AddedFeb 18, 2024
UpdatedJun 18, 2026
MYi

MYi

Pre-Seed

MYI Diagnostics: Pioneering precision medicine through multiplexed proteomic profiling and targeted diagnostics research.

HQ
San Francisco, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees

MYI Diagnostics is a biomedical research company specializing in multiplexed proteomic profiling for precision medicine. The company aims to replace targeted diagnostics for various cancers, infectious diseases, metabolic conditions, and other disorders. MYI Diagnostics generates actionable individualized information to streamline clinical interventions.

Founded by Nicholas J. Schork and Devon C, MYI Diagnostics has made significant strides in precision medicine. The company's research has the potential to revolutionize diagnostics and treatment strategies, impacting patient outcomes positively.

MYi - Similar Companies

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

ActivSignal logo

ActivSignal

activsignal.com

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

BioAnalytics logo

BioAnalytics

Empowered Diagnostics logo

Empowered Diagnostics

Myriad Genetics logo

Myriad Genetics

myriad.com

MeCo Diagnostics logo

MeCo Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Instadiagnostics logo

Instadiagnostics

Accelevir Diagnostics logo

Accelevir Diagnostics

MultiplexDX logo

MultiplexDX

multiplexdx.com

Miodx logo

Miodx

Micronoma logo

Micronoma

micronoma.com

Amplified Sciences logo

Amplified Sciences

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

MYi - Quick Facts

Who are MYi's competitors?

Companies similar to MYi include FYR Diagnostics, ActivSignal, Predictive Health Diagnostics Company and BioAnalytics.

When was MYi founded?

MYi was founded in 2015.

Where is MYi's headquarters located?

MYi's headquarters is located in San Francisco, CA, US.

When was MYi's last funding round?

MYi's most recent funding round was for $250k (USD) in September 2015.

How much has MYi raised to-date?

As of Sep 4, 2015, MYi has raised a total of $250k (USD).

How many employees does MYi have?

MYi has 6 employees as of Feb 4, 2024.

MYi - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Biotech
  • Research
Tags
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research